Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

NCT05388435 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped The study has been terminated based on portfolio prioritization. No safety trends or issues were identified at any dose level.

Conditions

Interventions

Sponsor

SK Life Science, Inc.